Rios Israel 4
4 · SCICLONE PHARMACEUTICALS INC · Filed May 16, 2011
Insider Transaction Report
Form 4
Rios Israel
Chief Medical Officer
Transactions
- Award
Non-Qualified Stock Option
2011-05-12$5.13/sh+40,000$205,200→ 40,000 totalExercise: $5.13Exp: 2021-05-12→ Common Stock (40,000 underlying) - Award
Non-Qualified Stock Option
2011-05-12$5.13/sh+40,000$205,200→ 40,000 totalExercise: $5.13Exp: 2021-05-12→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]25% of such shares vest April 5, 2012 and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
- [F3]Provided Reporting Person remains employed by the Issuer, the Option will vest 100% based on the achievement of a certain performance target on or prior to December 31, 2013. If this target is not achieved on or before December 31, 2013, the Option will not vest and will terminate at that time.